Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Novadiol
AddedFeb 16, 2024
UpdatedJun 18, 2026
Novadiol

Novadiol

Kansas-based Novadiol, Inc. develops innovative, low-risk medicines for kidney diseases, focusing on SHPT treatment.

HQ
Shawnee, KS, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Novadiol, Inc., founded in Kansas City, is a biopharmaceutical company dedicated to improving the lives of people with kidney diseases. The company's core mission is to develop innovative, low-risk medicines, with a particular focus on treating secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients. Their flagship product, Dendocrin, is a late-stage candidate aimed at addressing SHPT and vitamin D deficiency. By re-positioning existing compounds with well-known safety profiles, Novadiol aims to reduce development costs and risks.

Notable figures affiliated with Novadiol include leading nephrologists and pharmaceutical experts who contribute to the company's research and development efforts. The company has attracted significant interest from investors focused on healthcare innovations. Key achievements include advancing Dendocrin through late-stage clinical trials and securing patent protection for their drug formulations. Overall, Novadiol's impact lies in its potential to offer safer, more cost-effective treatments for CKD patients, addressing a significant unmet medical need.

Novadiol - Similar Companies

NephroDI Therapeutics logo

NephroDI Therapeutics

nephrodi.com

Novita Therapeutics logo

Novita Therapeutics

NovaDerm Aid logo

NovaDerm Aid

NovelMed Therapeutics logo

NovelMed Therapeutics

novelmed.com

KinDex Pharmaceuticals logo

KinDex Pharmaceuticals

Deltanoid Pharmaceuticals logo

Deltanoid Pharmaceuticals

Novelix Pharmaceuticals logo

Novelix Pharmaceuticals

Palladio Biosciences logo

Palladio Biosciences

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Xdynia logo

Xdynia

Hepanova logo

Hepanova

hepanova.com

Nephrogen logo

Nephrogen

Neurodon logo

Neurodon

neurodon.net

MediciNova logo

MediciNova

medicinova.com

Novidan logo

Novidan

Novadiol - Quick Facts

Who are Novadiol's competitors?

Companies similar to Novadiol include NephroDI Therapeutics, Novita Therapeutics, NovaDerm Aid and NovelMed Therapeutics.

When was Novadiol founded?

Novadiol was founded in 2012.

Where is Novadiol's headquarters located?

Novadiol's headquarters is located in Shawnee, KS, US.

When was Novadiol's last funding round?

Novadiol's most recent funding round was for $1.1M (USD) in July 2014.

How much has Novadiol raised to-date?

As of Jul 11, 2014, Novadiol has raised a total of $1.2M (USD).

How many employees does Novadiol have?

Novadiol has 6 employees as of Feb 5, 2024.

Novadiol - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified